All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Endocrine therapy

Nubeqa

(darolutamide)

Uses, side effects, dosage information & price range

Bayer AG

About this medicine

NUBEQA is indicated for the treatment of adult men with non?metastatic castration resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease (see section 5.1). metastatic hormone?sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (see section 5.1). metastatic hormone?sensitive prostate cancer (mHSPC) in combination with docetaxel and androgen deprivation therapy (see section 5.1).

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

EtcamahComposition: camizestrantAstraZeneca AB
Price on RequestView Details →
CamceviComposition: leuprorelinAccord Healthcare S.L.U.
Price on RequestView Details →
ErleadaComposition: apalutamideJanssen-Cilag International NV
Price on RequestView Details →
XtandiComposition: enzalutamideAstellas Pharma Europe B.V.
Price on RequestView Details →
OrserduComposition: elacestrantStemline Therapeutics B.V.
Price on RequestView Details →

Key Information

Salt / Composition

darolutamide

Category

Endocrine therapy

Manufacturer

Bayer AG

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.